• Annexin V-FITC/7-AAD Apoptosis Kit Workflow

  2026-09-10

  Build a rapid, dual-parameter workflow for separating viable, early apoptotic, late apoptotic, and necrotic cells. Apply it to lactoferrin-processing studies, cell viability assays, and cytotoxicity comparisons while keeping membrane-based evidence distinct from pathway-level conclusions.

• PBA-Modified PAD4 Inhibitors Block Tumor NETs

  2026-09-09

  This study developed phenylboronic acid (PBA)-modified PAD4 inhibitors to improve tumor localization and suppress the PAD4-H3cit-NETs pathway in neutrophils. Compound 5i reduced tumor growth and lung metastasis in mouse models while showing limited direct tumor-cell cytotoxicity, supporting a strategy based on tumor targeting and microenvironmental regulation.

• Dabigatran: From Target Engagement to Assay Meaning

  2026-09-09

  Dabigatran and Pradaxa are more than direct thrombin inhibitors: they are tools for connecting molecular target engagement with clinically meaningful coagulation data. This evidence-aware guide shows how to interpret assay endpoints, metabolites, matrix effects, and safety implications without confusing laboratory potency with clinical performance.

• Calcein AM/PI: Making Ferroptosis Translatable

  2026-09-08

  A mechanistic and translational framework for using Calcein AM/PI live/dead fluorescence to strengthen ferroptosis studies in mammalian cancer models.

• Melatonin-Tuned LNPs Improve NRF2 mRNA MSC Therapy

  2026-09-08

  The reference study develops melatonin-tuned lipid nanoparticles that improve cytosolic delivery of Nrf2 mRNA and functionally enhance mesenchymal stem cells for pulmonary fibrosis therapy. Its central contribution is linking lipid membrane fluidity, endosomal escape, antioxidant MSC programming, and reduced fibrotic remodeling within one delivery strategy.

• Porous Graphene MSI Maps Brain Lipid Asymmetry

  2026-09-07

  The reference study introduces laser-induced graphene as a matrix-free substrate for high-resolution laser desorption/ionization mass spectrometry imaging. Its application to ethanol-exposed mouse brains reveals time-dependent left–right asymmetry in nine lipid species, demonstrating how porous graphene can simplify MSI while preserving spatially resolved metabolic information.

• Annexin V-PE Reagent: From Signal to Decision

  2026-09-07

  Annexin V-PE Reagent enables rapid phosphatidylserine externalization detection, but its greatest value comes from disciplined interpretation. This article connects Annexin V-based readouts with CD38 CAR-binder engineering, assay controls, and mechanism-aware cell death decisions.

• LY294002 Workflows for PI3K Pathway Research

  2026-09-05

  LY294002 provides a reversible, cell-permeable approach for testing class I PI3K control of Akt/mTOR signaling, proliferation, apoptosis, and autophagosome formation. This practical guide connects dose-response experiments with cancer, ovarian carcinoma, and zebrafish angiogenesis workflows while highlighting off-target and cross-domain limitations.

• Panobinostat and the RNF20/RNF40/WAC Axis in MLL-ALL

  2026-09-04

  This study demonstrates that panobinostat produces strong anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia in xenograft models and links that response to loss of H2B ubiquitination. Its combination of in vivo efficacy, molecular profiling, and WAC knockdown identifies the RNF20/RNF40/WAC-H2B pathway as a mechanistically relevant epigenetic vulnerability.

• DAPI Workflows for Apoptosis and Nuclear Imaging

  2026-09-04

  Build reproducible DAPI assays for nuclear visualization, membrane-integrity screening, apoptosis-oriented imaging, and flow cytometry. This guide connects DAPI staining to the senescent nucleus pulposus cell–macrophage model and emphasizes controls, quantitative readouts, and troubleshooting.

• Z-WEHD-FMK for Caspase-1 Pyroptosis Studies

  2026-09-03

  Z-WEHD-FMK provides a cell-permeable, irreversible way to test whether inflammatory caspases drive pyroptosis, pathogen-associated organelle remodeling, or related cell-death phenotypes. This workflow connects the HOXC8–CASP1 axis in lung cancer with practical controls for infection models, including timing, orthogonal readouts, and troubleshooting.

• Parathyroid hormone (1-34) (human) Workflows

  2026-09-03

  Build reproducible cAMP, calcium-regulation, bone, and CKD-associated valvular calcification assays with a defined PTH1R-active peptide fragment. This guide connects concentration-controlled signaling experiments with the Foxp1–Notch–EndMT mechanism reported in a 2026 reference study.

• Annexin V-FITC/7-AAD Apoptosis Kit Guide

  2026-09-02

  The Annexin V-FITC/7-AAD Apoptosis Kit supports rapid separation of viable, Annexin V-positive, and membrane-compromised cell populations for cell viability assays, cytotoxicity assays, and routine cell death analysis. It is suitable for flow cytometry or fluorescence microscopy, but the two-color readout should not be used alone to establish a molecular death pathway or distinguish every form of late apoptosis from primary necrosis.

• Diphenyleneiodonium Chloride in Nrf2 Assays

  2026-09-02

  Diphenyleneiodonium chloride (DPI) can sharpen Nrf2 and oxidative-stress experiments when redox inhibition, proteasomal turnover, and cAMP signaling are separated analytically. This guide translates rotavirus–Nrf2 findings into a rigorous assay strategy while defining DPI’s mechanistic limits.

• Prevotella copri, IPyA, and Breast Cancer Progression

  2026-09-01

  A 2024 Gut Microbes study links enrichment of Prevotella copri with breast cancer progression through microbial consumption of tryptophan and depletion of host indole-3-pyruvic acid (IPyA). The work proposes an intestine–metabolite–epigenetic signaling axis in which reduced IPyA strengthens UHRF1-mediated inhibition of AMPK, offering a mechanistic framework for studying microbiota-associated tumor growth.

580 records 7/39 page Previous Next First page 上5页 678910 下5页 Last page